Abstract:The process of developing new drugs is widely acknowledged as being time-intensive and requiring substantial financial investment. Despite ongoing efforts to reduce time and expenses in drug development, ensuring medication safety remains an urgent problem. One of the major problems involved in drug development is hepatotoxicity, specifically known as drug-induced liver injury (DILI). The popularity of new drugs often poses a significant barrier during development and frequently leads to their recall after launch. In silico methods have many advantages compared with traditional in vivo and in vitro assays. To establish a more precise and reliable prediction model, it is necessary to utilize an extensive and high-quality database consisting of information on drug molecule properties and structural patterns. In addition, we should also carefully select appropriate molecular descriptors that can be used to accurately depict compound characteristics. The aim of this study was to conduct a comprehensive investigation into the prediction of DILI. First, we conducted a comparative analysis of the physicochemical properties of extensively well-prepared DILI-positive and DILI-negative compounds. Then, we used classic substructure dissection methods to identify structural pattern differences between these two different types of chemical molecules. These findings indicate that it is not feasible to establish property or substructure-based rules for distinguishing between DILI-positive and DILI-negative compounds. Finally, we developed quantitative classification models for predicting DILI using the naïve Bayes classifier (NBC) and recursive partitioning (RP) machine learning techniques. The optimal DILI prediction model was obtained using NBC, which combines 21 physicochemical properties, the VolSurf descriptors and the LCFP_10 fingerprint set. This model achieved a global accuracy (GA) of 0.855 and an area under the curve (AUC) of 0.704 for the training set, while the corresponding values were 0.619 and 0.674 for the test set, respectively. Moreover, indicative substructural fragments favorable or unfavorable for DILI were identified from the best naïve Bayesian classification model. These findings may help prioritize lead compounds in the early stage of drug development pipelines.

A Retrospective Study to Evaluate Hy's Law, DrILTox ALF Score, Robles-Diaz Model, and a New Logistic Regression Model for Predicting Acute Liver Failure in Chinese Patients with Drug-Induced Liver Injury.

A Prediction Model for COVID-19 Liver Dysfunction in Patients with Normal Hepatic Biochemical Parameters

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Prognostic Models for Acute Liver Failure.

A new prognostic model for drug-induced liver injury especially suitable for Chinese population

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.

Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury

S2002 A New 3-variable Model Outperforms MELD and King's College Criteria in Hospitalized Patients With Severe Idiosyncratic DILI

Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury

Evidence-based Incorporation of Key Parameters into MELD Score for Acute-on-chronic Liver Failure

The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.

Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.

Comparative Analysis of Machine Learning Models for Prediction of Acute Liver Injury in Sepsis Patients

Comparison of the prognostic models for mortality in idiosyncratic drug-induced liver injury

A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures

Logistic Regression Model Can Reduce Unnecessary Artificial Liver Support in Hepatitis B Virus-Associated Acute-On-Chronic Liver Failure: Decision Curve Analysis

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development